Skip to main content

Atea Pharmaceuticals, Inc.

AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001593899

In the last 90 days, Atea Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 126 institutions reported holding it in 13F filings for Q3 2026, worth $307.4M in total; no superinvestor holds it.

Holders of 5% or more of AVIR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Atea Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of AVIR
HolderLatest formStakeChangeFirst filedLatest filingFiling
FMR LLC13G/A15.00%12.0M shares+3.40 ppfrom 11.60%Feb 8, 202110 filingsMay 6, 2026SEC
Sommadossi Jean-Pierre13G/A11.00%9.08M shares+0.90 ppfrom 10.10%Feb 10, 20216 filingsNov 13, 2026SEC
BML Investment Partners, L.P.13G9.90%7.81M shares+1.40 ppfrom 8.50%Oct 2, 20235 filingsFeb 9, 2026SEC
BlackRock, Inc.13G/A7.10%6.08M shares–Apr 23, 20251 filingApr 23, 2025SEC
Tang Capital Management LLC13G6.00%4.81M sharesNewOct 6, 20261 filingOct 6, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

52 Schedule 13D and 13G filings on Atea Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on AVIR
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 13, 20264:43 PM ETSommadossi Jean-Pierreand 1 other13G/A11.00%9.08M shares+0.90 ppfrom 10.10%Sep 30, 2026SEC
Oct 6, 20266:20 PM ETTang Capital Management LLCand 5 others13G6.00%4.81M sharesNewOct 6, 2026SEC
May 6, 202611:00 AM ETFMR LLCand 1 other13G/A15.00%12.0M shares+3.40 ppfrom 11.60%Mar 31, 2026SEC
Mar 26, 20264:11 PM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Feb 9, 20262:02 PM ETBML Investment Partners, L.P.and 1 other13G9.90%7.81M shares+1.40 ppfrom 8.50%Dec 31, 2025SEC
Dec 5, 20252:03 PM ETFMR LLCand 1 other13G/A11.60%9.10M shares+4.90 ppfrom 6.70%Nov 28, 2025SEC
Aug 6, 202511:51 AM ETFMR LLCand 1 other13G/A6.70%5.72M shares–Jun 30, 2025SEC
May 14, 20256:21 PM ETSommadossi Jean-Pierreand 1 other13G/A10.10%8.88M shares–Mar 31, 2025SEC
Apr 23, 20258:14 PM ETBlackRock, Inc.13G/A7.10%6.08M shares–Mar 31, 2025SEC
Apr 17, 202512:23 PM ETRadoff Bradley Louisand 9 others13D/A4.00%3.38M shares+0.40 ppfrom 3.60%Below 5%Apr 16, 2025SEC
Mar 21, 202511:58 AM ETRadoff Bradley Louisand 9 others13D/A3.60%3.11M shares+0.30 ppfrom 3.30%Below 5%Mar 20, 2025SEC
Mar 4, 20259:27 AM ETRadoff Bradley Louisand 5 others13D3.30%2.82M sharesNewBelow 5%Feb 27, 2025SEC
Feb 14, 202512:47 PM ETEcoR1 Capital, LLCand 2 others13G/A4.00%3.34M shares–Below 5%Dec 31, 2024SEC
Dec 16, 20249:50 AM ETBML Investment Partners, L.P.and 1 other13D8.50%7.22M shares–Dec 13, 2024SEC
Nov 14, 2024EcoR1 Capital, LLC13G/AOld format–––SEC
Nov 12, 2024FMR LLC13G/AOld format–––SEC
Feb 14, 2024EcoR1 Capital, LLC13G/AOld format–––SEC
Feb 14, 2024EcoR1 Capital, LLC13G/AOld format–––SEC
Feb 14, 2024EcoR1 Capital, LLC13G/AOld format–––SEC
Feb 13, 2024Sommadossi Jean-Pierre13G/AOld format–––SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2024FMR LLC13G/AOld format–––SEC
Feb 7, 2024BML Investment Partners, L.P.13G/AOld format–––SEC
Feb 7, 2024BML Investment Partners, L.P.13GOld format–––SEC
Jan 24, 20249:46 AM ETBlackRock Inc.13G/AOld format–––SEC
Nov 28, 2023Tang Capital Partners LP13D/AOld format–––SEC
Nov 7, 20233:33 PM ETBlackRock Inc.13G/AOld format–––SEC
Oct 2, 2023BML Investment Partners, L.P.13GOld format–New–SEC
Sep 11, 2023FMR LLC13G/AOld format–––SEC
May 22, 2023Tang Capital Partners LP13DOld format–New–SEC
Feb 10, 2023Sommadossi Jean-Pierre13G/AOld format–––SEC
Feb 10, 2023EcoR1 Capital, LLC13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2023FMR LLC13G/AOld format–––SEC
Jan 24, 20231:56 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 16, 2022Morningside Venture Investments Ltd13G/AOld format–––SEC
Feb 14, 2022Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2022Cormorant Asset Management, LP13G/AOld format–––SEC
Feb 10, 2022Sommadossi Jean-Pierre13G/AOld format–––SEC
Feb 9, 2022Vanguard Group Inc13GOld format–New–SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Feb 4, 20224:12 PM ETBlackRock Inc.13GOld format–New–SEC
Dec 10, 2021EcoR1 Capital, LLC13GOld format–New–SEC
Sep 24, 2021Bain Capital Life Sciences Fund II, L.P.13D/AOld format–––SEC
Sep 3, 2021Bain Capital Life Sciences Fund II, L.P.13D/AOld format–––SEC
Apr 7, 2021Ra Capital Management, L.P.13G/AOld format–––SEC
Mar 10, 2021FMR LLC13G/AOld format–––SEC
Feb 16, 2021Ra Capital Management, L.P.13GOld format–New–SEC
Feb 16, 2021Morningside Venture Investments Ltd13GOld format–New–SEC
Feb 16, 2021Cormorant Asset Management, LP13G/AOld format–––SEC

Form 144: proposed insider sales

16 notices from officers, directors and other affiliates planning to sell Atea Pharmaceuticals, Inc. shares, newest first.

Form 144 notices for AVIR
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Nov 18, 20265:04 PM ETBruce PolskyDirector18.3K$72.1KNov 18, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Nov 17, 20264:37 PM ETBruce PolskyDirector8.72K$35.2KNov 17, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Nov 17, 20264:23 PM ETBruno LucidiDirector6.74K$27.2KNov 17, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Nov 16, 20264:12 PM ETBruce PolskyDirector14.3K$60.8KNov 16, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Dec 10, 20245:17 PM ETFranklin BergerLead Independent Director359.6K$1.02MDec 10, 2024J.P. Morgan Securities LLCSEC
Sep 19, 20244:22 PM ETJPM Partners LLCAffiliate1.84K$7.37KSep 19, 202410b5-1UBS Financial Services Inc.SEC
Sep 18, 20244:09 PM ETJPM Partners LLCAffiliate22.2K$89.5KSep 18, 202410b5-1UBS Financial Services Inc.SEC
Sep 17, 20244:16 PM ETJPM Partners LLCAffiliate33.9K$137.3KSep 17, 202410b5-1UBS Financial Services Inc.SEC
Jun 20, 20245:32 PM ETPolsky BruceDirector17.5K$68.8KJun 20, 2024MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICESSEC
Jun 5, 20244:04 PM ETJPM Partners LLCAffiliate1.01K$4.02KJun 5, 202410b5-1UBS Financial Services Inc.SEC
Feb 1, 20244:15 PM ETWayne FosterEVP, Chief Accounting Officer14.3K$58.2KFeb 1, 202410b5-1Morgan StanleySEC
Feb 1, 20244:15 PM ETJean-Pierre SommadossiPresident, CEO, and Chairman65.5K$266.5KFeb 1, 202410b5-1Morgan StanleySEC
Feb 1, 20244:15 PM ETJanet MJ HammondChief Development Officer16.1K$65.6KFeb 1, 202410b5-1Morgan StanleySEC
Feb 1, 20244:15 PM ETJohn VavrickaChief Commercial Officer13.6K$55.2KFeb 1, 202410b5-1Morgan StanleySEC
Feb 1, 20244:15 PM ETMaria Arantxa HorgaChief Medical Officer18.2K$74.2KFeb 1, 202410b5-1Morgan StanleySEC
Feb 1, 20244:15 PM ETAndrea CorcoranCFO, EVP, Legal and Secretary18.2K$74.1KFeb 1, 202410b5-1Morgan StanleySEC